TACSTD2 and colorectal carcinoma: A similar diverging pattern was observed in relation to MSI and p53 status: TROP2 expression demonstrated prognostic significance solely in MSS CRC and those with abnormal p53 expression, with no survival distinctions noted in MSI‐high or p53 wild‐type neoplasms.